<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>43</number>
    <updateDate>2025-03-31T14:51:43Z</updateDate>
    <updateDateIncludingText>2025-03-31T14:51:43Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2025-01-09</introducedDate>
    <congress>119</congress>
    <committees>
      <item>
        <systemCode>ssju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2025-01-09T19:38:28Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2025-01-09</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2025-01-09</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>H000273</bioguideId>
        <fullName>Sen. Hickenlooper, John W. [D-CO]</fullName>
        <firstName>John</firstName>
        <lastName>Hickenlooper</lastName>
        <party>D</party>
        <state>CO</state>
        <middleName>W.</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>W000800</bioguideId>
        <fullName>Sen. Welch, Peter [D-VT]</fullName>
        <firstName>Peter</firstName>
        <lastName>Welch</lastName>
        <party>D</party>
        <state>VT</state>
        <sponsorshipDate>2025-01-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001095</bioguideId>
        <fullName>Sen. Cotton, Tom [R-AR]</fullName>
        <firstName>Tom</firstName>
        <lastName>Cotton</lastName>
        <party>R</party>
        <state>AR</state>
        <sponsorshipDate>2025-01-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001035</bioguideId>
        <fullName>Sen. Collins, Susan M. [R-ME]</fullName>
        <firstName>Susan</firstName>
        <lastName>Collins</lastName>
        <party>R</party>
        <state>ME</state>
        <middleName>M.</middleName>
        <sponsorshipDate>2025-01-09</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Commerce</name>
    </policyArea>
    <subjects>
      <legislativeSubjects/>
      <policyArea>
        <name>Commerce</name>
        <updateDate>2025-02-10T20:03:12Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2025-01-09</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2025-03-31T14:51:02Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Skinny Labels, Big Savings Act&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill provides a statutory safe harbor from patent infringement claims for generic or&amp;nbsp;biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs.&lt;/p&gt;&lt;p&gt;Under current law, the Food and Drug Administration (FDA) may approve generic and&amp;nbsp;biosimilar drugs through a process known as skinny labeling, which allows a generic manufacturer to seek approval only for approved uses of the drug that are no longer protected by patents. However, in &lt;em&gt;GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.&lt;/em&gt;, a court held that a generic manufacturer may sometimes be liable for patent infringement when it markets skinny label generics.&lt;/p&gt;&lt;p&gt;The bill specifically lists the following as actions that are not considered infringement of a method of use claim in a patent under the Federal Food, Drug, and Cosmetic Act:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;submitting or seeking approval of a skinny label for a generic or biosimilar drug;&lt;/li&gt;&lt;li&gt;promoting or commercially marketing a drug with skinny labeling approved by the FDA; or&lt;/li&gt;&lt;li&gt;describing a drug product approved by the FDA as a generic of, or therapeutically equivalent to, the branded drug.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;The bill also applies the safe harbor to similar actions under the Public Health Service Act.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Skinny Labels, Big Savings Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Skinny Labels, Big Savings Act</title>
        <updateDate>2025-02-08T05:08:20Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Skinny Labels, Big Savings Act</title>
        <updateDate>2025-02-08T05:08:18Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.</title>
        <updateDate>2025-02-08T05:03:27Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2025-01-09T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119s43is/xml/BILLS-119s43is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2025-01-09</actionDate>
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
